New questions over use of statins

Statins provide no benefit for primary cardiovascular disease prevention in patients older than 65, a study shows.

A post-hoc analysis of data from the ALLHAT-LLT trial shows pravastatin sodium at 40mg/day is not associated with any improvement over usual care for rates of coronary heart disease or all-cause mortality.

And among people older than 75, there’s a non-significant trend towards higher all-cause mortality, researchers say.

Patients in the US National Heart, Lung and Blood Institute study of nearly 3000 people older than 65 had moderate hyperlipidaemia